LOSS OF DONOR CHIMERISM IN PATIENT UNDERGOING ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT FOR MDS.

被引：0
|
作者：
Kashi, Zahra [1 ]
Pourani, Parisa [1 ]
Martin, Russ [1 ]
Bryant, Margi [2 ]
机构：
[1] HLA, Kashi Clin Labs, Portland, OR USA
[2] Jewish Hosp Cincinnati, Blood & Marrow Transplant Ctr, Cincinnati, OH USA
来源：
HUMAN IMMUNOLOGY | 2013年 / 74卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：121 / 121
页数：1
相关论文
共 50 条
  • [1] Early Mixed Donor Chimerism is a Strong Negative Prognostic Indicator in Allogeneic Stem Cell Transplant for AML and MDS
    Radford, Michael
    Garcia-Horton, Alejandro
    Badami, Rohail
    Jin, Elaine
    Usmani, Nida
    Grafodatskaya, Daria
    Mccready, Elizabeth
    Khalaf, Dina
    Walker, Irwin
    Leber, Brian
    Lepic, Kylie
    Pond, Gregory
    Berg, Tobias
    TRANSPLANTATION AND CELLULAR THERAPY, 2025, 31 (02): : 77e1 - 77e20
  • [2] Sirolimus (rapamycin) induced proteinuria in a patient undergoing allogeneic hematopoietic stem cell transplant
    Jhaveri, Kenar D.
    Schatz, Jonathan H.
    Young, James W.
    Flombaum, Carlos
    TRANSPLANTATION, 2008, 86 (01) : 180 - 181
  • [3] Impact of prior solid tumor on outcomes of allogeneic hematopoietic stem cell transplantation for AML or MDS.
    Albittar, Aya
    Portuguese, Andrew Jay
    Gooley, Ted
    Deeg, H. Joachim
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [4] Allogeneic hematopoietic stem cell transplantation (HSCT) for patients aged 65 years or older with AML and MDS.
    de Lima, M
    Shahjahan, M
    Alamo, J
    Williams, P
    von Wolff, B
    Couriel, D
    Khouri, I
    Rondon, G
    Wheeler, B
    Estey, E
    Ueno, N
    Kebriaei, P
    Champlin, R
    Giralt, S
    BLOOD, 2004, 104 (11) : 632A - 633A
  • [5] Leukemia in donor cells after allogeneic hematopoietic stem cell transplant
    Brunstein, CG
    Hirsch, BA
    Hammerschmidt, D
    McGlennen, RC
    Nguyen, PL
    Verfaillie, CM
    BONE MARROW TRANSPLANTATION, 2002, 29 (12) : 999 - 1003
  • [6] Leukemia in donor cells after allogeneic hematopoietic stem cell transplant
    CG Brunstein
    BA Hirsch
    D Hammerschmidt
    RC McGlennen
    PL Nguyen
    CM Verfaillie
    Bone Marrow Transplantation, 2002, 29 : 999 - 1003
  • [7] DONOR T-CELL CHIMERISM AND EARLY POST-TRANSPLANT CYTOMEGALOVIRUS VIREMIA IN PATIENTS TREATED WITH MYELOABLATIVE ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT
    Taimur, S.
    Askar, M.
    Sobecks, R.
    Rybicki, L.
    Warshawsky, I
    Mossad, S.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (02) : S356 - S356
  • [8] Donor T-cell chimerism and early post-transplant cytomegalovirus viremia in patients treated with myeloablative allogeneic hematopoietic stem cell transplant
    Taimur, S.
    Askar, M.
    Sobecks, R.
    Rybicki, L.
    Warshawsky, I.
    Mossad, S.
    TRANSPLANT INFECTIOUS DISEASE, 2014, 16 (01) : 61 - 66
  • [9] Full donor chimerism after allogeneic hematopoietic stem cells transplant for myelofibrosis: The role of the conditioning regimen
    Chiusolo, Patrizia
    Bregante, Stefania
    Giammarco, Sabrina
    Lamparelli, Teresa
    Casarino, Lucia
    Dominietto, Alida
    Raiola, Anna Maria
    Metafuni, Elisabetta
    Di Grazia, Carmen
    Gualandi, Francesca
    Sora, Federica
    Laurenti, Luca
    Sica, Simona
    Barosi, Gianni
    Guolo, Fabio
    Rossi, Monica
    Rossi, Elena
    Vannucchi, Alessandro
    Signori, Alessio
    De Stefano, Valerio
    Bacigalupo, Andrea
    Angelucci, Emanuele
    AMERICAN JOURNAL OF HEMATOLOGY, 2021, 96 (02) : 234 - 240
  • [10] No effect of aging on the donor hematopoietic stem cell compartment in allogeneic stem cell transplant.
    Arora, A
    Sharp, JG
    Lynch, JC
    Kessinger, A
    BLOOD, 2004, 104 (11) : 783A - 783A
12345